Literature DB >> 24887793

The impact of regionalization of pancreaticoduodenectomy for pancreatic Cancer in North Carolina since 2004.

Ryan Z Swan1, David J Niemeyer, Ramanathan M Seshadri, Kyle J Thompson, Amanda Walters, John B Martinie, David Sindram, David A Iannitti.   

Abstract

Pancreaticoduodenectomy (PD) carries a significant risk. High-volume centers (HVCs) provide improved outcomes and regionalization is advocated. Rapid regionalization could, however, have detrimental effects. North Carolina has multiple HVCs, including an additional HVC added in late 2006. We investigated regionalization of PD and its effects before, and after, the establishment of this fourth HVC. The North Carolina Hospital Discharge Database was queried for all PDs performed during 2004 to 2006 and 2007 to 2009. Hospitals were categorized by PD volume as: low (one to nine/year), medium (10 to 19/year), and high (20/year or more). Mortality and major morbidity was assessed by comparing volume groups across time periods. Number of PDs for cancer increased 91 per cent (129 to 246 cases) at HVCs, whereas decreasing at low-volume (62 to 58 cases) and medium-volume (80 to 46 cases) centers. Percentage of PD for cancer performed at HVCs increased significantly (47.6 to 70.3%) while decreasing for low- and medium-volume centers (P < 0.001). Mortality was significantly less at HVCs (2.8%) compared with low-volume centers (10.3%) for 2007 to 2009. Odds ratio for mortality was significantly lower at HVCs during 2004 to 2006 (0.31) and 2007 to 2009 (0.34). Mortality for PD performed for cancer decreased from 6.6 to 4.6 per cent (P = 0.31). Major morbidity was not significantly different between groups within either time period; however, there was a significant increase in major morbidity at low-volume centers (P = 0.018). Regionalization of PD for cancer is occurring in North Carolina. Mortality was significantly lower at HVCs, and rapid regionalization has not detracted from the superior outcomes at HVCs.

Entities:  

Mesh:

Year:  2014        PMID: 24887793

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  9 in total

Review 1.  Robotic pancreaticoduodenectomy for pancreatic adenocarcinoma: role in 2014 and beyond.

Authors:  Erin H Baker; Samuel W Ross; Ramanathan Seshadri; Ryan Z Swan; David A Iannitti; Dionisios Vrochides; John B Martinie
Journal:  J Gastrointest Oncol       Date:  2015-08

2.  The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy.

Authors:  Daniel J Kagedan; Nik Goyert; Qing Li; Lawrence Paszat; Alexander Kiss; Craig C Earle; Paul J Karanicolas; Alice C Wei; Nicole Mittmann; Natalie G Coburn
Journal:  J Gastrointest Surg       Date:  2017-01-05       Impact factor: 3.452

3.  Why Do Long-Distance Travelers Have Improved Pancreatectomy Outcomes?

Authors:  Manila Jindal; Chaoyi Zheng; Humair S Quadri; Chukwuemeka U Ihemelandu; Young K Hong; Andrew K Smith; Vikas Dudeja; Nawar M Shara; Lynt B Johnson; Waddah B Al-Refaie
Journal:  J Am Coll Surg       Date:  2017-04-14       Impact factor: 6.113

4.  The Importance of Safety-Net Hospitals in Emergency General Surgery.

Authors:  Vikrom K Dhar; Young Kim; Koffi Wima; Richard S Hoehn; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2018-07-23       Impact factor: 3.452

Review 5.  Recent Advances in Pancreatic Cancer Surgery.

Authors:  Laura Maggino; Charles M Vollmer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

6.  Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?

Authors:  Lauren M Perry; Sarah B Bateni; Richard J Bold; Jeffrey S Hoch
Journal:  J Am Coll Surg       Date:  2021-03-22       Impact factor: 6.113

7.  The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis.

Authors:  Benjamin D Powers; William Fulp; Amina Dhahri; Danielle K DePeralta; Takuya Ogami; Luke Rothermel; Jennifer B Permuth; Susan T Vadaparampil; Joon-Kyung Kim; Jose Pimiento; Pamela J Hodul; Mokenge P Malafa; Daniel A Anaya; Jason B Fleming
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 13.787

8.  Variation in survival after surgery for peri-ampullary cancer in a regional cancer network.

Authors:  Bassem Amr; Golnaz Shahtahmassebi; Somaiah Aroori; Matthew J Bowles; Christopher D Briggs; David A Stell
Journal:  BMC Surg       Date:  2017-03-07       Impact factor: 2.102

9.  Regional oncology network between pancreatic centers safeguards waiting times for pancreatoduodenectomy.

Authors:  M Willemijn Steen; Claire van Vliet; Sebastiaan Festen; Marc G Besselink; Michael F Gerhards; Olivier R Busch
Journal:  Updates Surg       Date:  2019-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.